Colorectal Carcinoma
|
0.660 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Adenocarcinoma of lung (disorder)
|
0.650 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Adenocarcinoma of large intestine
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Achondroplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
|
8078586 |
1994 |
Achondroplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
|
7758520 |
1995 |
Achondroplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Achondroplasia is defined by recurrent G380R mutations of FGFR3.
|
7847369 |
1995 |
Hypochondroplasia (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
We now report a single FGFR3 mutation found in 8 out of 14 unrelated patients with hypochondroplasia.
|
7670477 |
1995 |
Thanatophoric dysplasia, type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
|
7773297 |
1995 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A sporadic mutation causing a Lys650Glu change in the tyrosine kinase domain of FGFR3 was found in 16 of 16 individuals with one type of TD.
|
7773297 |
1995 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I.
|
8589699 |
1995 |
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder)
|
0.780 |
GeneticVariation
|
disease |
UNIPROT |
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
|
7493034 |
1995 |
Achondroplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
|
8599935 |
1996 |
Thanatophoric dysplasia, type 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The mechanism of FGFR3 activation in TDII was probed by constructing various point mutations in the activation loop.
|
8754806 |
1996 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Here, we report the identification of FGFR3 mutations in 25/26 TD cases.
|
8845844 |
1996 |
Muenke Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.
|
9042914 |
1997 |
Hypochondroplasia (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Here we report an A to G transition at position 1651, predicting an Ile538Val substitution in the FGFR3, in hypochondroplasia.
|
10215410 |
1998 |
Hypochondroplasia (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia.
|
9452043 |
1998 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
In conclusion, we have identified the G370C mutation in the FGFR3 gene in a Japanese TD1 patient.
|
9790257 |
1998 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Lys650Met substitution in the tyrosine kinase domain of the fibroblast growth factor receptor gene causes thanatophoric dysplasia Type I. Mutations in brief no. 199. Online.
|
10671061 |
1998 |
Muenke Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.
|
9950359 |
1999 |
Malignant neoplasm of urinary bladder
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
|
10471491 |
1999 |
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
We examined 22 cases of TD variants for the presence of missense mutations in the fibroblast growth factor receptor 3 (FGFR3) gene.
|
10360402 |
1999 |
Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
We refer to the phenotype caused by the Lys650Met mutation as "severe achondroplasia with developmental delay and acanthosis nigricans" (SADDAN) because it differs significantly from the phenotypes of other known FGFR3 mutations.
|
10053006 |
1999 |
cervical cancer
|
0.540 |
GeneticVariation
|
disease |
UNIPROT |
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
|
10471491 |
1999 |
Achondroplasia
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.
|
10611230 |
2000 |